Showing 2 posts of 2 posts found.
Freeline Therapeutics has announced that it has entered into a definitive agreement with newly established portfolio company Syncona, in which …
The UK is making a £30 million R&D investment into a promising new type of cancer treatment and is to …
Care Quality Commission appoints Emily Miles as Chief Executive
National survey aims to improve glaucoma care across the UK
Phase 3 trials support expanded use of Dysport for migraine prevention
Roche secures CE Mark for automated latent tuberculosis blood test
ReproNovo Phase 2 fertility study doses first participant